Farallon Capital Management, L.L.C. added $21.9M of MAZE stock

SEC Form 13F · Filed Aug 14, 2026

Farallon Capital Management, L.L.C. added $21.9M of Maze Therapeutics, Inc. (MAZE) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 14, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

MAZE

Maze Therapeutics, Inc.

Value

$21.9M

Disclosed: Aug 14, 2026
Quarter end: Jun 30, 2026
Source: SEC Form 13F

See the filing

More MAZE insider and Congress trades

SellMAZE · Jason Coloma V$1MNov 4, 2026
SellMAZE · Atul Dandekar$241KOct 30, 2026
SellMAZE · Jason Coloma V$932KOct 2, 2026
SellMAZE · Harold Bernstein$435KOct 2, 2026
SellMAZE · Atul Dandekar$203KOct 1, 2026
SellMAZE · Harold Bernstein$255KSep 8, 2026

More changes from this filing

BuyACHC$84MAug 14, 2026
BuyAVTX$32.5MAug 14, 2026
BuyAZN$64.2MAug 14, 2026
SellBBNX$26.8MAug 14, 2026
BuyBIDU$88.1MAug 14, 2026
SellBITW$26.9MAug 14, 2026

Share this trade